Global Metabolomics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 103162
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Metabolomics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Metabolomics market size is estimated to be worth US$ 1463.9 million in 2021 and is forecast to a readjusted size of USD 2967.7 million by 2028 with a CAGR of 10.6% during review period. Drug Assessment accounting for % of the Metabolomics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Separation Techniques segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Metabolomics include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Biocrates Life Sciences AG, Shimadzu Corporation, and Waters Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Metabolomics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Separation Techniques

Detection Techniques

Others

Market segment by Application, can be divided into

Drug Assessment

Biomarker Discovery

Nutrigenomics

Clinical toxicology

Others

Market segment by players, this report covers

Thermo Fisher Scientific, Inc.

Agilent Technologies, Inc.

Biocrates Life Sciences AG

Shimadzu Corporation

Waters Corporation

Human Metabolome Technologies, Inc.

LECO Corporation

Metabolon, Inc.

Bio-Rad Laboratories, Inc.

Bruker Corporation

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Metabolomics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Metabolomics, with revenue, gross margin and global market share of Metabolomics from 2019 to 2022.

Chapter 3, the Metabolomics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Metabolomics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Metabolomics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Metabolomics

1.2 Classification of Metabolomics by Type

1.2.1 Overview: Global Metabolomics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Metabolomics Revenue Market Share by Type in 2021

1.2.3 Separation Techniques

1.2.4 Detection Techniques

1.2.5 Others

1.3 Global Metabolomics Market by Application

1.3.1 Overview: Global Metabolomics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Drug Assessment

1.3.3 Biomarker Discovery

1.3.4 Nutrigenomics

1.3.5 Clinical toxicology

1.3.6 Others

1.4 Global Metabolomics Market Size & Forecast

1.5 Global Metabolomics Market Size and Forecast by Region

1.5.1 Global Metabolomics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Metabolomics Market Size by Region, (2017-2022)

1.5.3 North America Metabolomics Market Size and Prospect (2017-2028)

1.5.4 Europe Metabolomics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Metabolomics Market Size and Prospect (2017-2028)

1.5.6 South America Metabolomics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Metabolomics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Metabolomics Market Drivers

1.6.2 Metabolomics Market Restraints

1.6.3 Metabolomics Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Thermo Fisher Scientific, Inc.

2.1.1 Thermo Fisher Scientific, Inc. Details

2.1.2 Thermo Fisher Scientific, Inc. Major Business

2.1.3 Thermo Fisher Scientific, Inc. Metabolomics Product and Solutions

2.1.4 Thermo Fisher Scientific, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

2.2 Agilent Technologies, Inc.

2.2.1 Agilent Technologies, Inc. Details

2.2.2 Agilent Technologies, Inc. Major Business

2.2.3 Agilent Technologies, Inc. Metabolomics Product and Solutions

2.2.4 Agilent Technologies, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans

2.3 Biocrates Life Sciences AG

2.3.1 Biocrates Life Sciences AG Details

2.3.2 Biocrates Life Sciences AG Major Business

2.3.3 Biocrates Life Sciences AG Metabolomics Product and Solutions

2.3.4 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Biocrates Life Sciences AG Recent Developments and Future Plans

2.4 Shimadzu Corporation

2.4.1 Shimadzu Corporation Details

2.4.2 Shimadzu Corporation Major Business

2.4.3 Shimadzu Corporation Metabolomics Product and Solutions

2.4.4 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Shimadzu Corporation Recent Developments and Future Plans

2.5 Waters Corporation

2.5.1 Waters Corporation Details

2.5.2 Waters Corporation Major Business

2.5.3 Waters Corporation Metabolomics Product and Solutions

2.5.4 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Waters Corporation Recent Developments and Future Plans

2.6 Human Metabolome Technologies, Inc.

2.6.1 Human Metabolome Technologies, Inc. Details

2.6.2 Human Metabolome Technologies, Inc. Major Business

2.6.3 Human Metabolome Technologies, Inc. Metabolomics Product and Solutions

2.6.4 Human Metabolome Technologies, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Human Metabolome Technologies, Inc. Recent Developments and Future Plans

2.7 LECO Corporation

2.7.1 LECO Corporation Details

2.7.2 LECO Corporation Major Business

2.7.3 LECO Corporation Metabolomics Product and Solutions

2.7.4 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 LECO Corporation Recent Developments and Future Plans

2.8 Metabolon, Inc.

2.8.1 Metabolon, Inc. Details

2.8.2 Metabolon, Inc. Major Business

2.8.3 Metabolon, Inc. Metabolomics Product and Solutions

2.8.4 Metabolon, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Metabolon, Inc. Recent Developments and Future Plans

2.9 Bio-Rad Laboratories, Inc.

2.9.1 Bio-Rad Laboratories, Inc. Details

2.9.2 Bio-Rad Laboratories, Inc. Major Business

2.9.3 Bio-Rad Laboratories, Inc. Metabolomics Product and Solutions

2.9.4 Bio-Rad Laboratories, Inc. Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

2.10 Bruker Corporation

2.10.1 Bruker Corporation Details

2.10.2 Bruker Corporation Major Business

2.10.3 Bruker Corporation Metabolomics Product and Solutions

2.10.4 Bruker Corporation Metabolomics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Bruker Corporation Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Metabolomics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Metabolomics Players Market Share in 2021

3.2.2 Top 10 Metabolomics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Metabolomics Players Head Office, Products and Services Provided

3.4 Metabolomics Mergers & Acquisitions

3.5 Metabolomics New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Metabolomics Revenue and Market Share by Type (2017-2022)

4.2 Global Metabolomics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Metabolomics Revenue Market Share by Application (2017-2022)

5.2 Global Metabolomics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Metabolomics Revenue by Type (2017-2028)

6.2 North America Metabolomics Revenue by Application (2017-2028)

6.3 North America Metabolomics Market Size by Country

6.3.1 North America Metabolomics Revenue by Country (2017-2028)

6.3.2 United States Metabolomics Market Size and Forecast (2017-2028)

6.3.3 Canada Metabolomics Market Size and Forecast (2017-2028)

6.3.4 Mexico Metabolomics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Metabolomics Revenue by Type (2017-2028)

7.2 Europe Metabolomics Revenue by Application (2017-2028)

7.3 Europe Metabolomics Market Size by Country

7.3.1 Europe Metabolomics Revenue by Country (2017-2028)

7.3.2 Germany Metabolomics Market Size and Forecast (2017-2028)

7.3.3 France Metabolomics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Metabolomics Market Size and Forecast (2017-2028)

7.3.5 Russia Metabolomics Market Size and Forecast (2017-2028)

7.3.6 Italy Metabolomics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Metabolomics Revenue by Type (2017-2028)

8.2 Asia-Pacific Metabolomics Revenue by Application (2017-2028)

8.3 Asia-Pacific Metabolomics Market Size by Region

8.3.1 Asia-Pacific Metabolomics Revenue by Region (2017-2028)

8.3.2 China Metabolomics Market Size and Forecast (2017-2028)

8.3.3 Japan Metabolomics Market Size and Forecast (2017-2028)

8.3.4 South Korea Metabolomics Market Size and Forecast (2017-2028)

8.3.5 India Metabolomics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Metabolomics Market Size and Forecast (2017-2028)

8.3.7 Australia Metabolomics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Metabolomics Revenue by Type (2017-2028)

9.2 South America Metabolomics Revenue by Application (2017-2028)

9.3 South America Metabolomics Market Size by Country

9.3.1 South America Metabolomics Revenue by Country (2017-2028)

9.3.2 Brazil Metabolomics Market Size and Forecast (2017-2028)

9.3.3 Argentina Metabolomics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Metabolomics Revenue by Type (2017-2028)

10.2 Middle East & Africa Metabolomics Revenue by Application (2017-2028)

10.3 Middle East & Africa Metabolomics Market Size by Country

10.3.1 Middle East & Africa Metabolomics Revenue by Country (2017-2028)

10.3.2 Turkey Metabolomics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Metabolomics Market Size and Forecast (2017-2028)

10.3.4 UAE Metabolomics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Metabolomics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Metabolomics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Metabolomics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Metabolomics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Metabolomics Revenue Market Share by Region (2023-2028)

Table 6. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Thermo Fisher Scientific, Inc. Major Business

Table 8. Thermo Fisher Scientific, Inc. Metabolomics Product and Solutions

Table 9. Thermo Fisher Scientific, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Agilent Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Agilent Technologies, Inc. Major Business

Table 12. Agilent Technologies, Inc. Metabolomics Product and Solutions

Table 13. Agilent Technologies, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Biocrates Life Sciences AG Corporate Information, Head Office, and Major Competitors

Table 15. Biocrates Life Sciences AG Major Business

Table 16. Biocrates Life Sciences AG Metabolomics Product and Solutions

Table 17. Biocrates Life Sciences AG Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Shimadzu Corporation Corporate Information, Head Office, and Major Competitors

Table 19. Shimadzu Corporation Major Business

Table 20. Shimadzu Corporation Metabolomics Product and Solutions

Table 21. Shimadzu Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Waters Corporation Corporate Information, Head Office, and Major Competitors

Table 23. Waters Corporation Major Business

Table 24. Waters Corporation Metabolomics Product and Solutions

Table 25. Waters Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Human Metabolome Technologies, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. Human Metabolome Technologies, Inc. Major Business

Table 28. Human Metabolome Technologies, Inc. Metabolomics Product and Solutions

Table 29. Human Metabolome Technologies, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. LECO Corporation Corporate Information, Head Office, and Major Competitors

Table 31. LECO Corporation Major Business

Table 32. LECO Corporation Metabolomics Product and Solutions

Table 33. LECO Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Metabolon, Inc. Corporate Information, Head Office, and Major Competitors

Table 35. Metabolon, Inc. Major Business

Table 36. Metabolon, Inc. Metabolomics Product and Solutions

Table 37. Metabolon, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Bio-Rad Laboratories, Inc. Major Business

Table 40. Bio-Rad Laboratories, Inc. Metabolomics Product and Solutions

Table 41. Bio-Rad Laboratories, Inc. Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Bruker Corporation Corporate Information, Head Office, and Major Competitors

Table 43. Bruker Corporation Major Business

Table 44. Bruker Corporation Metabolomics Product and Solutions

Table 45. Bruker Corporation Metabolomics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Metabolomics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Metabolomics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Metabolomics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Metabolomics Players Head Office, Products and Services Provided

Table 50. Metabolomics Mergers & Acquisitions in the Past Five Years

Table 51. Metabolomics New Entrants and Expansion Plans

Table 52. Global Metabolomics Revenue (USD Million) by Type (2017-2022)

Table 53. Global Metabolomics Revenue Share by Type (2017-2022)

Table 54. Global Metabolomics Revenue Forecast by Type (2023-2028)

Table 55. Global Metabolomics Revenue by Application (2017-2022)

Table 56. Global Metabolomics Revenue Forecast by Application (2023-2028)

Table 57. North America Metabolomics Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Metabolomics Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Metabolomics Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Metabolomics Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Metabolomics Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Metabolomics Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Metabolomics Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Metabolomics Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Metabolomics Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Metabolomics Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Metabolomics Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Metabolomics Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Metabolomics Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Metabolomics Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Metabolomics Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Metabolomics Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Metabolomics Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Metabolomics Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Metabolomics Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Metabolomics Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Metabolomics Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Metabolomics Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Metabolomics Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Metabolomics Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Metabolomics Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Metabolomics Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Metabolomics Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Metabolomics Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Metabolomics Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Metabolomics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Metabolomics Picture

Figure 2. Global Metabolomics Revenue Market Share by Type in 2021

Figure 3. Separation Techniques

Figure 4. Detection Techniques

Figure 5. Others

Figure 6. Metabolomics Revenue Market Share by Application in 2021

Figure 7. Drug Assessment Picture

Figure 8. Biomarker Discovery Picture

Figure 9. Nutrigenomics Picture

Figure 10. Clinical toxicology Picture

Figure 11. Others Picture

Figure 12. Global Metabolomics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Metabolomics Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Metabolomics Revenue Market Share by Region (2017-2028)

Figure 15. Global Metabolomics Revenue Market Share by Region in 2021

Figure 16. North America Metabolomics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Metabolomics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Metabolomics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Metabolomics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Metabolomics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Metabolomics Market Drivers

Figure 22. Metabolomics Market Restraints

Figure 23. Metabolomics Market Trends

Figure 24. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans

Figure 25. Agilent Technologies, Inc. Recent Developments and Future Plans

Figure 26. Biocrates Life Sciences AG Recent Developments and Future Plans

Figure 27. Shimadzu Corporation Recent Developments and Future Plans

Figure 28. Waters Corporation Recent Developments and Future Plans

Figure 29. Human Metabolome Technologies, Inc. Recent Developments and Future Plans

Figure 30. LECO Corporation Recent Developments and Future Plans

Figure 31. Metabolon, Inc. Recent Developments and Future Plans

Figure 32. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans

Figure 33. Bruker Corporation Recent Developments and Future Plans

Figure 34. Global Metabolomics Revenue Share by Players in 2021

Figure 35. Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Metabolomics Revenue Market Share in 2021

Figure 37. Global Top 10 Players Metabolomics Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Metabolomics Revenue Share by Type in 2021

Figure 40. Global Metabolomics Market Share Forecast by Type (2023-2028)

Figure 41. Global Metabolomics Revenue Share by Application in 2021

Figure 42. Global Metabolomics Market Share Forecast by Application (2023-2028)

Figure 43. North America Metabolomics Sales Market Share by Type (2017-2028)

Figure 44. North America Metabolomics Sales Market Share by Application (2017-2028)

Figure 45. North America Metabolomics Revenue Market Share by Country (2017-2028)

Figure 46. United States Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Metabolomics Sales Market Share by Type (2017-2028)

Figure 50. Europe Metabolomics Sales Market Share by Application (2017-2028)

Figure 51. Europe Metabolomics Revenue Market Share by Country (2017-2028)

Figure 52. Germany Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Metabolomics Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Metabolomics Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Metabolomics Revenue Market Share by Region (2017-2028)

Figure 60. China Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Metabolomics Sales Market Share by Type (2017-2028)

Figure 67. South America Metabolomics Sales Market Share by Application (2017-2028)

Figure 68. South America Metabolomics Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Metabolomics Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Metabolomics Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Metabolomics Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Metabolomics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz